These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37672669)

  • 1. Roadmap to VIRTUAL-GLOBAL: coordinating VItiligo RegisTries for adUlts And chiLdren internationally.
    Eleftheriadou V; Hamzavi I; Bae JM; Ezzedine K
    Br J Dermatol; 2023 Dec; 190(1):114-116. PubMed ID: 37672669
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic options and hot topics in vitiligo with special focus on pediatrics' vitiligo: A comprehensive review study.
    Roohaninasab M; Mansouri P; Seirafianpour F; Naeini AJ; Goodarzi A
    Dermatol Ther; 2021 Jan; 34(1):e14550. PubMed ID: 33200859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of vitiligo and inflammatory arthropathy in hospitalized US adults.
    Patel KR; Justiz AM; Ahmed AM; Silverberg JI
    J Am Acad Dermatol; 2023 Dec; 89(6):1256-1257. PubMed ID: 37532138
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of hypopigmentation in children.
    Schaffer JV; Bolognia JL
    Clin Dermatol; 2003; 21(4):296-310. PubMed ID: 14572700
    [No Abstract]   [Full Text] [Related]  

  • 5. Defining the psychological comorbidity in vitiligo: systematically casting the net wide.
    Thomson J
    Br J Dermatol; 2018 Apr; 178(4):826. PubMed ID: 29668098
    [No Abstract]   [Full Text] [Related]  

  • 6. Global recommendations for vitiligo management.
    Ring J
    J Eur Acad Dermatol Venereol; 2023 Nov; 37(11):2157-2158. PubMed ID: 37877761
    [No Abstract]   [Full Text] [Related]  

  • 7. Radiotherapy-induced vitiligo: A systematic review of patient demographics and clinical characteristics of vitiligo following radiation therapy.
    Mansour MR; Abushukur Y; Rehman RA; Shah C; Mehregan D
    J Am Acad Dermatol; 2022 Dec; 87(6):1445-1448. PubMed ID: 35995610
    [No Abstract]   [Full Text] [Related]  

  • 8. Demographic and clinical characteristics of patients with both psoriasis and vitiligo in a cohort of vitiligo patients: a cross-sectional study.
    Canu D; Shourick J; Andreu N; Gey A; Ballanger-Désolneux F; Barailler H; Boniface K; Ezzedine K; Seneschal J
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):e676-e679. PubMed ID: 34013570
    [No Abstract]   [Full Text] [Related]  

  • 9. Views on vitiligo disease course and treatment among people living with vitiligo and healthcare providers worldwide.
    Br J Dermatol; 2023 Oct; 189(5):e94. PubMed ID: 37879743
    [No Abstract]   [Full Text] [Related]  

  • 10. Global clinicoepidemiological pattern of childhood vitiligo: a systematic review and meta-analysis.
    Farajzadeh S; Khalili M; Mirmohammadkhani M; Paknazar F; Rastegarnasab F; Abtahi-Naeini B
    BMJ Paediatr Open; 2023 Apr; 7(1):. PubMed ID: 37616066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special Considerations in Children with Vitiligo.
    Taïeb A; Seneschal J; Mazereeuw-Hautier J
    Dermatol Clin; 2017 Apr; 35(2):229-233. PubMed ID: 28317531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demographics of Vitiligo in the DataDerm Database.
    Cunningham KN; Alsukait S; Learned C; Deverapalli S; Aninos A; Rosmarin D
    J Cutan Med Surg; 2023; 27(5):529-530. PubMed ID: 37522738
    [No Abstract]   [Full Text] [Related]  

  • 13. Ultra-violet therapy in cases of leucoderma.
    MENON AN
    Ind Med Gaz; 1945 Dec; 80(12):612-4. PubMed ID: 21026566
    [No Abstract]   [Full Text] [Related]  

  • 14. Global VALIANT study: 'lifting the lid' on disappointment and frustration with the lack of effective treatment for vitiligo.
    Ahmed A; Eleftheriadou V
    Br J Dermatol; 2023 Nov; 189(6):e99-e102. PubMed ID: 37705206
    [No Abstract]   [Full Text] [Related]  

  • 15. Vitiligo and leukoderma in children.
    Herane MI
    Clin Dermatol; 2003; 21(4):283-95. PubMed ID: 14572699
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychological comorbidities of vitiligo: a retrospective cross-sectional analysis in an urban population.
    Montgomery SN; Syder N; Barajas G; Elbuluk N
    Arch Dermatol Res; 2023 Dec; 316(1):14. PubMed ID: 38047925
    [No Abstract]   [Full Text] [Related]  

  • 17. Vitiligo in underrepresented communities: An All of Us database analysis.
    Ahmed F; Moseley I; Ragi SD; Ouellette S; Rao B
    J Am Acad Dermatol; 2023 Apr; 88(4):945-948. PubMed ID: 36414097
    [No Abstract]   [Full Text] [Related]  

  • 18. The Incidence, Prevalence, and Mortality of Vitiligo in Korea: A Nationwide Population-Based Cohort Study.
    Lee YB; Kim S; Kim HS
    J Cutan Med Surg; 2023; 27(2):166-167. PubMed ID: 36579730
    [No Abstract]   [Full Text] [Related]  

  • 19. Expanding the White Armor of Vitiligo.
    Pearson TF; Harris JE
    J Invest Dermatol; 2024 Jan; 144(1):5-7. PubMed ID: 37831052
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitiligo.
    LeWitt TM; Kundu RV
    JAMA Dermatol; 2021 Sep; 157(9):1136. PubMed ID: 34287629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.